---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-21-032255"
form_type: "8-K"
ticker: "ERNA"
cik: "0000748592"
company_name: "Ernexa Therapeutics Inc."
filed_at: "2021-09-23T23:59:59+00:00"
generated_at: "2026-06-29T01:53:52.331267+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Brooklyn ImmunoTherapeutics appoints CMO Roger Sidhu, outlines gene editing strategy; appoints Marcum as auditor

## Summary
- Roger Sidhu appointed CMO effective Sept 20, 2021; receives option for 161,300 shares and RSU for 80,650 shares, base salary $447,200.
- Bylaws amended to remove CFO position; VP of Finance Sandra Gurrola serves as principal financial officer.
- Marcum LLP appointed as new independent auditor for FY2021 after dismissal of Baker Tilly.
- Shareholder update call: plans to use iMSCs for allogeneic bone marrow transplants, gene editing for solid tumors and monogenic disorders.
- Dr. Sidhu previously at Kite Pharma (Gilead), Roivant Sciences, Cell Design Labs, Amgen; M.D. from Queen's University.

## SEC filing metadata
- accession: 0001140361-21-032255
- form_type: 8-K
- ticker: ERNA
- cik: 0000748592
- company_name: Ernexa Therapeutics Inc.
- filed_at: 2021-09-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 4.01, 5.02, 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/748592/000114036121032255/0001140361-21-032255-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/748592/000114036121032255/brhc10029142_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-21-032255
- JSON: https://secwatch.observer/filing/0001140361-21-032255.json
- Plain text: https://secwatch.observer/filing/0001140361-21-032255.txt

## Key facts
- Executive change
  Roger Sidhu was appointed as Chief Medical Officer at Ernexa Therapeutics Inc..
  - Action: appointed
  - Role: Chief Medical Officer
  source text: On September 22, 2021, we announced that Roger Sidhu had been appointed as our Chief Medical Officer, effective September 20, 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/748592/000114036121032255/0001140361-21-032255-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.